Importancia de los virus en las exacerbaciones de Enfermedad Pulmonar Obstructiva Crónica (EPOC). ¿Podría cambiar su comportamiento durante la pandemia de SARS-COV-2 (COVID-19)?

Resumen

La pandemia por SARS-COV-2 ha generado muchos interrogantes sobre el comportamiento de enfermedades crónicas. Si bien se conoce que los pacientes con comorbilidades importantes tienen un mayor riesgo de complicaciones, no se conoce el comportamiento de enfermedades, como la enfermedad pulmonar obstructiva crónica (EPOC), en el período de pandemia y cuarentena por covid-19. En este artículo, se realizó una revisión de la literatura sobre los principales aspectos teóricos para entender las posibles interacciones entre la infección por SARS-COV-2 y pacientes con patología respiratoria como la EPOC. Se revisaron los principales aspectos de las infecciones virales y su fisiopatología en la exacerbación de la enfermedad, sus mecanismos inflamatorios, y las condiciones que pueden aumentar el riesgo de infección y gravedad durante la pandemia por covid-19. Además, se exploraron los aspectos relacionados a la cuarentena y su posible influencia sobre la exacerbación de la enfermedad. Finalmente, se exploraron los aspectos económicos relacionados con la exacerbación y su manejo asociado a la pandemia.

Biografía del autor/a

Alirio Rodrigo Bastidas Goyes , Universidad de la Sabana. Chía, Colombia

Médico especialista en Medicina Interna y Neumología. Magister en Epidemiología. Profesor asistente. Facultad de Medicina. Universidad de la Sabana. Chía, Colombia.
Correo electrónico: alirio.bastidas@unisabana.edu.co

Paula Oriana Narváez Ramírez, Universidad de la Sabana. Chía, Colombia

Estudiante de Medicina. Universidad de la Sabana. Chía, Colombia.
ORCID: https://orcid.org/0000-0001-9099-646X Correo: paulanara@unisabana.edu.co

Laura Sofía Perdomo Rodríguez, Universidad de la Sabana. Chía, Colombia

Estudiante de Medicina. Universidad de la Sabana. Chía, Colombia.
ORCID: https://orcid.org/0000-0002-9397-0772 Correo: lauraperrod@unisabana.edu.co

 

 

Luis Miguel Vargas Arcila, Universidad de la Sabana. Chía, Colombia

Estudiante de Medicina. Universidad de la Sabana. Chía, Colombia.
ORCID: https://orcid.org/0000-0001-8606-8994 Correo: luisvaar@unisabana.edu.co

Gustavo Adolfo Hincapié Díaz, Universidad Militar Nueva Granada. Bogotá, Colombia
Médico especialista en Medicina Interna y Neumología. Profesor asociado. Coordinador del programa de Neumología. Jefe del servicio de Neumología del Hospital Militar Central. Universidad Militar Nueva Granada. Bogotá, Colombia.
ORCID: http://orcid.org/0000-0002-5220-5193 Correo electrónico: gustavo.hincapie@unimilitar.edu.co    
Claudia Liliana Echeverría González, Universidad Militar Nueva Granada. Bogotá, Colombia
Médica especialista en Pediatría. Magister en Epidemiología. Directora de posgrados médicos. Epidemióloga de la Unidad de Investigación Clínica del Hospital Militar Central. Universidad Militar Nueva Granada. Bogotá, Colombia.
ORCID: http://orcid.org/0000-0002-6410-7451 Correo: clecheverriag@gmail.com

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Alirio Rodrigo Bastidas Goyes , Universidad de la Sabana. Chía, Colombia

Médico especialista en Medicina Interna y Neumología. Magister en Epidemiología. Profesor asistente. Facultad de Medicina. Universidad de la Sabana. Chía, Colombia.
Correo electrónico: alirio.bastidas@unisabana.edu.co

Paula Oriana Narváez Ramírez, Universidad de la Sabana. Chía, Colombia

Estudiante de Medicina. Universidad de la Sabana. Chía, Colombia.
ORCID: https://orcid.org/0000-0001-9099-646X Correo: paulanara@unisabana.edu.co

Laura Sofía Perdomo Rodríguez, Universidad de la Sabana. Chía, Colombia

Estudiante de Medicina. Universidad de la Sabana. Chía, Colombia.
ORCID: https://orcid.org/0000-0002-9397-0772 Correo: lauraperrod@unisabana.edu.co

 

 

Luis Miguel Vargas Arcila, Universidad de la Sabana. Chía, Colombia

Estudiante de Medicina. Universidad de la Sabana. Chía, Colombia.
ORCID: https://orcid.org/0000-0001-8606-8994 Correo: luisvaar@unisabana.edu.co

Gustavo Adolfo Hincapié Díaz, Universidad Militar Nueva Granada. Bogotá, Colombia
Médico especialista en Medicina Interna y Neumología. Profesor asociado. Coordinador del programa de Neumología. Jefe del servicio de Neumología del Hospital Militar Central. Universidad Militar Nueva Granada. Bogotá, Colombia.
ORCID: http://orcid.org/0000-0002-5220-5193 Correo electrónico: gustavo.hincapie@unimilitar.edu.co    
Claudia Liliana Echeverría González, Universidad Militar Nueva Granada. Bogotá, Colombia
Médica especialista en Pediatría. Magister en Epidemiología. Directora de posgrados médicos. Epidemióloga de la Unidad de Investigación Clínica del Hospital Militar Central. Universidad Militar Nueva Granada. Bogotá, Colombia.
ORCID: http://orcid.org/0000-0002-6410-7451 Correo: clecheverriag@gmail.com

Referencias Bibliográficas

Guan W, Ni Z, Hu Y, Liang W, P Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. [Internet]. 2020 abr; 382: 1708-120. Disponible en: https://www.nejm.org/doi/full/10.1056/nejmoa2002032 DOI: https://doi.org/10.1056/NEJMoa2002032

Disponible en: https://www.paho.org/col/index.php?option=com_content&view=article&id=3331:la-oms-declara-que-el-nuevo-brote-de-coronavirus-es-una-emergencia-de-salud-publica-de-importancia-internacional&Itemid=562

Organización Panamericana de la Salud, Organización Mundial de la Salud. Actualización epidemiológica del nuevo coronavirus (covid-19). Washington: OPS, OMS; 2020. Disponible en: https://www.paho.org/sites/default/files/2020-02/2020-feb-14-phe-actualizacion-epi-covid19.pdf

Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. [Internet]. 2019 mar; 17(3): 181-192. Disponible en: https://www.nature.com/articles/s41579-018-0118-9 DOI: https://doi.org/10.1038/s41579-018-0118-9

Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. covid-19 does not lead to a "typical" acute respiratory distress syndrome. Am J Respir Crit Care Med. [Internet]. 2020 may; 201(10): 1299-1300. DOI: https://doi.org/10.1164/rccm.202003-0817LE

Organización Mundial de la Salud. Alocución del director general de la OMS en la rueda de prensa sobre la covid-19 celebrada el 11 de marzo de 2020. [Internet]. Disponible en: https://www.who.int/es/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020

Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with covid-19: evidence from meta-analysis. Aging. [Internet]. 2020 abr; 12(7): 6049-6057. Disponible en: https://www.aging-us.com/article/103000/text DOI: https://doi.org/10.18632/aging.103000

Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with covid-19: a systematic review and meta-analysis. Arch Acad Emerg Med. [Internet]. 2020 mar; 8(1): e35. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096724/ DOI: https://doi.org/10.1371/journal.pone.0241265 DOI: https://doi.org/10.1371/journal.pone.0241265

Guan W, Liang W, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis. Eur Respir J. [Internet]. 2020 may; 55(5): 2000547. Disponible en: https://erj.ersjournals.com/content/55/5/2000547 DOI: https://doi.org/10.1183/13993003.01227-2020

Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (covid-19). Respir Med. [Internet]. 2020 jun; 167: 105941. Disponible en: https://www.resmedjournal.com/article/S0954-6111(20)30081-0/fulltext DOI: https://doi.org/10.1016/j.rmed.2020.105941

Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. [Internet]. 2020 abr; 8(5): 436-438. Disponible en: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30167-3/fulltext DOI: https://doi.org/10.1016/S2213-2600(20)30167-3

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). Global Initiative for Chronic Obstructive Lung Disease; 2020. Disponible en: https://goldcopd.org/wp-content/uploads/2019/11/GOLD2020-REPORT-ver1.0wms.pdf

Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. [Internet]. 1987 feb; 106(2): 196-204. Disponible en: https://www.acpjournals.org/doi/10.7326/0003-4819-106-2-196 DOI: https://doi.org/10.7326/0003-4819-106-2-196

Kurai D, Saraya T, Ishii H, Takizawa H. Virus-induced exacerbations in asthma and COPD. Front Microbiol. [Internet]. 2013 oct; 4: 293. Disponible en: https://www.frontiersin.org/articles/10.3389/fmicb.2013.00293/full DOI: https://doi.org/10.3389/fmicb.2013.00293

García-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population-based cohort study. Thorax. [Internet]. 2006 sept; 61(9): 772-778. Disponible en: https://thorax.bmj.com/content/61/9/772 DOI: https://doi.org/10.1136/thx.2006.060145

Soler-Cataluña JJ, Martínez-García M, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. [Internet]. 2005 nov; 60(11): 925-931. DOI: https://doi.org/10.1136/thx.2005.040527

Hewitt R, Farne H, Ritchie A, Luke E, Johnston S L, Mallia, P. The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis. [Internet]. 2016; 10(2): 158-174. DOI: https://doi.org/10.1177/1753465815618113

Anzueto A. Impact of exacerbations on COPD. EurRespir Rev. [Internet]. 2010 jun; 19(116): 113-118. Disponible en: https://err.ersjournals.com/content/19/116/113 DOI: https://doi.org/10.1183/09059180.00002610

Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. [Internet]. 2003 ago; 124(2): 459-67. Disponible en: https://journal.chestnet.org/article/S0012-3692(15)33325-0/fulltext DOI: https://doi.org/10.1378/chest.124.2.459

Kherad O, Kaiser L, Bridevaux PO, Sarasin F, Thomas Y, Janssens JP, et al. Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest. [Internet]. 2010 oct; 138(4): 896-904. Disponible en: https://journal.chestnet.org/article/S0012-3692(10)60538-7/fulltext DOI: https://doi.org/10.1378/chest.09-2225

Spencer S, Jones P. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. [Internet]. 2003 jul; 58(7): 589-593. Disponible en: https://thorax.bmj.com/content/58/7/589 DOI: https://doi.org/10.1136/thorax.58.7.589

Perotin JM, Dury S, Renois F, Deslee G, Wolak A, Du- val V, et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol. [Internet]. 2013 may; 85(5): 866-873. DOI: https://doi.org/10.1002/jmv.23495

Lawrence H, Hunter A, Murray R, Lim WS, McKeever T. Cigarette smoking and the occurrence of influenza - Systematic review. J Infect. [Internet]. 2019 nov; 79(5): 401-406. DOI: https://doi.org/10.1016/j.jinf.2019.08.014

Atto B, Eapen-Mathew S, Sharma P, Frey U., Ammit AJ, Markos J, et al. New therapeutic targets for the prevention of infectious acute exacerbations of COPD: role of epithelial adhesion molecules and inflammatory pathways. Clin Sci. [Internet]. 2019 jul133(14): 1663- 1703 DOI: https://doi.org/10.1042/CS20181009

Eapen MS, Sharma P, Moodley YP, Hansbro PM, Sohal SS. Dysfunctional immunity and microbial adhesion molecules in smoking-induced pneumonia. Am J Respir Crit Care Med. [Internet]. 2019 ene; 199(2): 250-251. DOI: https://doi.org/10.1164/rccm.201808-1553LE

Kurai D, Saraya T, Ishiiand H, Takizawa H. Virus-induced exacerbations in asthma and COPD. Front Microbiol. [Internet]. 2013 oct; 293(4). Disponible en: https://doi.org/10.3389/fmicb.2013.00293

Importancia de los virus en las exacerbaciones de Enfermedad Pulmonar Obstructiva Crónica (EPOC). ¿Podría cambiar su comportamiento durante la pandemia de SARS-COV-2 (COVID-19)? en: https://www.frontiersin.org/articles/10.3389/fmicb.2013.00293/full DOI: https://doi.org/10.3389/fmicb.2013.00293

Eapen MS, Sharma P, Sohal S. Mitochondrial dysfunction in macrophages: a key to defective bacterial phagocytosis in COPD. Eur Respir J. [Internet]. 2019 oct; 54(4): 1901641. Disponible en: https://erj.ersjournals.com/content/54/4/1901641 DOI: https://doi.org/10.1183/13993003.01641-2019

Eapen MS, Sohal SS. Understanding novel mechanisms of microbial pathogenesis in chronic lung disease: Implications for new therapeutic targets. Clin Sci (Lond). [Internet]. 2018 feb; 132(3): 375-379. Disponible en: https://portlandpress.com/clinsci/article-abstract/132/3/375/72102/Understanding-novel-mechanisms-of-microbial?redirectedFrom=fulltext DOI: https://doi.org/10.1042/CS20171261

Sohal SS. Inhaled corticosteroids and increased microbial load in COPD: Potential role of epithelial adhesion molecules. Eur Respir J. [Internet]. 2018 ene; 51(2): 1702257. Disponible en: https://erj.ersjournals.com/content/51/2/1702257 DOI: https://doi.org/10.1183/13993003.02257-2017

Han L, Ran J, Mak YW, Suen LK, Lee PH, Peiris JSM, et al.Smoking and influenza-associated morbidity and mortality: a systematic Review and meta-analysis. Epidemiology. [Internet]. 2019 may; 30(3): 405- 417. Disponible en: https://journals.lww.com/epidem/Abstract/2019/05000/Smoking_and_Influenza_associated_Morbidity_and.15.aspx DOI: https://doi.org/10.1097/EDE.0000000000000984

Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, et al.Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation. Am J Respir Crit Care Med. [Internet]. 2011 mar; 183(6): 734-742. Disponible en: https://www.atsjournals.org/doi/full/10.1164/rccm.201006-0833OC DOI: https://doi.org/10.1164/rccm.201006-0833OC

Wilkinson T, Donaldson G, Johnston S, Openshaw P, Wedzicha J. Respiratory syncytial virus, airway inflammation, and fev1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. [Internet]. 2006 abr; 173(8): 871-876. Disponible en: https://www.atsjournals.org/doi/full/10.1164/rccm.200509-1489OC DOI: https://doi.org/10.1164/rccm.200509-1489OC

Seemungal T, Harper-Owen R, Bhowmik A, Sanderson G, Message S, MacCallum P, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. [Internet]. 2001 nov; 164(9): 1618-1623. Disponible en: https://www. atsjournals.org/doi/full/10.1164/ajrccm.164.9.2105011 DOI: https://doi.org/10.1164/ajrccm.164.9.2105011

Papi A, Bellettato CA, Braccioni F, Romagnoli M, Casolari P, Caramori G, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. [Internet]. 2006 may; 173(10): 1114-1121. DOI: https://doi.org/10.1164/rccm.200506-859OC

Frickmann H, Jungblut S, Hirche TO, Groß U, Kuhns M, Zautner AE. The influence of virus infections on the course of COPD. Eur J Microbiol Immunol. [Inter- net]. 2012 sept; 2(3): 176-185. Disponible en: https://akjournals.com/view/journals/1886/2/3/article-p176. xml DOI: https://doi.org/10.1556/EuJMI.2.2012.3.2

Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associa- ted SARS pneumonia: a prospective study. Lancet. [Internet]. 2003 may; 361(9371): 1767-1772. DOI: https://doi.org/10.1016/S0140-6736(03)13412-5

Memish ZA, Perlman S, Van Kerkhove MD, Zumla A. Middle east respiratory syndrome. Lancet. [Internet]. 2020 mar; 395(10229): 1063-1077. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)33221-0/fulltext DOI: https://doi.org/10.1016/S0140-6736(19)33221-0

Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Journal Emerging Microbes & Infections. [Internet]. 2020 dic; 9(1): 727-732. DOI: https://doi.org/10.1080/22221751.2020.1746199

Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-emc. Nature. [Internet]. 2013 mar; 495(7440): 251-254. DOI: https://doi.org/10.1038/nature12005

Coutard B, Valle C, Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. [Internet]. 2020 abr; 176: 104742. DOI: https://doi.org/10.1016/j.antiviral.2020.104742

Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell rna expression profiling of ace2, the putative receptor of Wuhan 2019-nCov. Am J Respir Crit Care Med. [Internet]. 2020 sept; 202(5): 756-759. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462411/ DOI: https://doi.org/10.1164/rccm.202001-0179LE

Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin - converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (covid-19). J Clin Med. [Internet]. 2020 mar; 9(3); 841. DOI: https://doi.org/10.3390/jcm9030841

Singh AK, Gupta R, Misra A. Comorbidities in covid-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr. [Internet]. 2020 ago; 14(4): 283- 287. Disponible en: https://www.sciencedirect.com/science/article/pii/S1871402120300564?via%3Dihub DOI: https://doi.org/10.1016/j.dsx.2020.03.016

Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, et al. ace-2 expression in the small airway epithelia of smokers and COPD patients: implications for covid-19. Eur Respir J. [Internet]. 2020 may; 55(5): 2000688. Disponible en: https://erj.ersjournals.com/content/55/5/2000688 DOI: https://doi.org/10.1183/13993003.00688-2020

Arnold F, Mahmood K, Angeline P, Aden D, Raghu- ram A, Burns MA, et al. COPD exacerbation caused by SARS-CoV-2: a case report from the Louisville covid-19 surveillance program. The Univ Louisville J Respir Infect. [Internet]. 2020; 4(1): artículo 5. Disponible en: https://ir.library.louisville.edu/jri/vol4/iss1/5/

Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. [Internet]. 2005 jul; 436(7047): 112-116. Disponible en: https://www.nature.com/articles/nature03712 DOI: https://doi.org/10.1038/nature03712

Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. [Internet]. 2020 may; 395(10235): 1517-1520. DOI: https://doi.org/10.1016/S0140-6736(20)30920-X

Jones PW, Lamarca R, Chuecos F, Singh D, Agustí A, Bateman ED, et al. Characterisation and impact of reported and unreported exacerbations: results from attain. Eur Resp J. [Internet]. 2014 nov; 44(5): 1156-1165. Disponible en: https://erj.ersjournals.com/content/44/5/1156 DOI: https://doi.org/10.1183/09031936.00038814

Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. [Internet]. 1998 may; 157(1): 1418-1422. Disponible en: https://www.atsjournals.org/doi/full/10.1164/ajrccm.157.5.9709032 DOI: https://doi.org/10.1164/ajrccm.157.5.9709032

Thomas Y, Boquete-Suter P, Koch D, Pittet D, Kaiser LL. Survival of influenza virus on human fingers. Clin Microbiol Infect. [Internet]. 2014 ene; 20(1): 92-93. Disponible en: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)60219-6/fulltext DOI: https://doi.org/10.1111/1469-0691.12324

Kac G, Podglajen I, Gueneret M, Vaupre S, Bissery A, Meyer G. Microbiological evaluation of two hand hygiene procedures achieved by healthcare workers during routine patient care: a randomized study. J Hosp Infect. [Internet]. 2005 may; 60(1): 32-39. DOI: https://doi.org/10.1016/j.jhin.2004.10.014

Zhou SS, Lukula S, Chiossone C, Nims RW, Suchmann DB, Ijaz MK. Assessment of a respiratory face mask for capturing air pollutants and pathogens including human influenza and rhinoviruses. J Thorac Dis. [Internet]. 2018 mar 10(3): 2059- 2069. Disponible en: https://jtd.amegroups.com/article/view/20136/15564 DOI: https://doi.org/10.21037/jtd.2018.03.103

Ma QX, Shan H, Zhang HL, Li GM, Yang RM, Chen JM. Potential utilities of mask‐wearing and instant hand hygiene for fighting SARS-CoV-2. J Med Virol. [Internet]. 2020 sept; 92(9): 1567-1571. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/jmv.25805 DOI: https://doi.org/10.1002/jmv.25805

McManus TE, Coyle PV, Kidney JC. Childhood respiratory infections and hospital admissions for copd. Resp Med. [Internet]. 2006 mar; 100(3): 512-518. DOI: https://doi.org/10.1016/j.rmed.2005.06.001

Greenberg SB. Viral respiratory infections in elderly patients and patients with chronic obstructive pulmonary disease. Am J of Med. [Internet]. 2002 abr; 112(6): 28-32. DOI: https://doi.org/10.1016/S0002-9343(01)01061-0

Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. [Internet]. 1996 sept; 154(3): 654-660. Disponible en: https://www.atsjournals.org/doi/abs/10.1164/ajrccm.154.3.8810601 DOI: https://doi.org/10.1164/ajrccm.154.3.8810601

Mannino D, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. [Internet]. 2007 oct; 4(7): 502- 506. Disponible en: https://pats.atsjournals.org/cgi/doi/10.1513/pats.200701-001FM DOI: https://doi.org/10.1513/pats.200701-001FM

Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ats/ers position paper. Eur Respir J. [Internet]. 2004 jun; 23(6): 932-946. Disponible en: https://erj.ersjournals.com/content/23/6/932 DOI: https://doi.org/10.1183/09031936.04.00014304

Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD [Internet]. 2010 jun; 7(3): 214-28. Disponible en: https://www.tandfonline.com/doi/abs/10.3109/15412555.2010.481697?journalCode=icop20 DOI: https://doi.org/10.3109/15412555.2010.481697

Simoens S, Decramer M, De Coster S, Celis G, Laekeman G. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations. Int J Clin Pract. [Internet]. 2007 feb; 61(2): 200-206. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2006.01240.x DOI: https://doi.org/10.1111/j.1742-1241.2006.01240.x

O'Reilly JF, Williams AE, Rice L. Health status impairment and costs associated with COPD exacerbation managed in hospital. Int J Clin Pract. [Internet]. 2007 jul; 61(7): 1112-1120. DOI: https://doi.org/10.1111/j.1742-1241.2007.01424.x

Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, FitzGerald JM. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. [Internet]. 2008 mar; 102(3): 413-421. DOI: https://doi.org/10.1016/j.rmed.2007.10.010

Oostenbrink JB, Rutten-van-Molken MPM. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med. [Internet]. 2004 sept; 98(9): 883-891. Disponible en: https://www.resmedjournal.com/article/S0954-6111(04)00082-4/fulltext DOI: https://doi.org/10.1016/j.rmed.2004.02.013

Cómo citar
Enciso Bahamón, L. F., Bastidas Goyes , A. R., Narváez Ramírez, P. O., Perdomo Rodríguez, L. S., Vargas Arcila, L. M., Hincapié Díaz, G. A., & Echeverría González, C. L. (2022). Importancia de los virus en las exacerbaciones de Enfermedad Pulmonar Obstructiva Crónica (EPOC). ¿Podría cambiar su comportamiento durante la pandemia de SARS-COV-2 (COVID-19)?. Revista Med, 29(2), 65-78. https://doi.org/10.18359/rmed.4873
Publicado
2022-08-01
Crossref Cited-by logo